Pancreatic cancer is a rare disease; however, its initially inconspicuous symptoms and aggressive nature make it one of the ...

A vitamin A byproduct has been found to quietly disarm the immune system, allowing tumors to evade attack and weakening ...

The preventive immunization Nous-209 works in an initial trial with patients who have 17 times the risk of developing tumors compared to the general population ...

Much of pancreatic cancer’s evasive and deadly nature may come down to low levels of one gene. In A Nutshell Early detection, ...

After years stuck in the “doldrums,” the biopharma sector is in a “very good place” heading into the new year, analysts told ...

The intricate relationship between diet, metabolic disorders, and cancer progression has garnered significant attention in ...

Lynch Syndrome (LS) is a common hereditary condition that significantly increases the lifetime risk of developing multiple cancersNOUS-209 is an off-the-shelf cancer immunotherapy designed to induce T ...

Eikon Therapeutics, Inc. eyes IPO to fund EIK1001 oncology pipeline; early Phase 2 data show 60% response rate. Click for ...

The discovery could pave the way for new treatments, improved risk prediction, and earlier intervention for brain metastases.

Multiple preservatives that are added to food products to lengthen their shelf life have significant associations with overall cancer development.

Seven in 10 people now survive their cancer five years or more, up from only half in the mid-70s,” said Rebecca Siegel, ...

The decision to end the programme comes 18 months after Genmab's former partner for the acasunlimab, BioNTech, pulled out of ...